and fabricators like UEC. This is effect to small volume for UEC in Q2/2018 and very high competition. Discussion and Analysis of the Company and its subsidiaries Operational Results in Q2/2018 and Q2
Company and its subsidiaries Operational Results in Q2/2020 and Q2/2019 Corporate Revenue In Q2/2020 the Company and its subsidiaries’ total earnings amount to Baht 193 million, consisting of Baht 191
price and time. Discussion and Analysis of the Company and its subsidiaries Operational Results in 2018 and 2017 Corporate Revenue In 2018 the Company and its subsidiaries’ total earnings amounted to 880
in fair value of financial assets measured at fair value through profit or loss. Discussion and Analysis of the Company and its subsidiaries’ Operational Results in Q1/2020 and Q1/2019 Corporate
analysis follow: Income Statements First quarter 2020 Operational Performance The Company reported Revenues from Hospital Operations of THB 183.19 million, a 8.41% decrease year‐over‐year from THB
17.91% in 2018 compared to 15.50% in 2017. Details of the management discussion and analysis follow: Income statements 2018 Operational Performance The Company reported Revenues from hospital operations
in 2018, with Net profit margin at 17.60% in 2019 compared to 17.91% in 2018. Details of the management discussion and analysis as follow: Income Statements 2019 Operational Performance The Company
Statements Second Quarterly Operational Performance The Company reported Revenues from Hospital Operations of THB 116.75 million, a 45.30 percent decrease from THB 213.42 million compared to the same period of
private fund; “Management company” means any mutual fund management company and private fund management company; “Mutual fund management company” means any securities company licensed to undertake